3Cairns P. Renal cell carcinoma[J].Cancer Biomark,2010,(1-6):461-473.
4Eisenhauer EA,Therasse P,Bogaerts J. New response evaluation criteria in solid tumours:revised RECIST guideline (version 1.1)[J].{H}EUROPEAN JOURNAL OF CANCER,2009,(02):228-247.
5Eggener SE,Rubenstein JN,Smith ND. Renal tumors in young adults[J].{H}Journal Of Urology,2004,(01):106-110.
6Blute ML,Itano NB,Cheville JC. The effect of bilaterality,pathological features and surgical outcome in nonhereditary renal cell carcinoma[J].{H}Journal Of Urology,2003,(04):1276-1281.
7McKiernan J,Simmons R,Katz J. Natural history of chronic renal insufficiency after partial and radical nephrectomy[J].{H}UROLOGY,2002,(06):816-820.
8Novick AC,Gephardt G,Guz B. Long-term follow-up after partial removal of a solitary kidney[J].{H}New England Journal of Medicine,1991,(15):1058-1062.
9Stadler WM,Huo D,George C. Progonstic factors for survival with gemcitabine plus 5-fluorouracil based regimens for metastatic renal cancer[J].{H}Journal Of Urology,2003,(4 Pt 1):1141-1145.
10Culine S,Iborra F,Mottet N. Subcutaneous interleukin-2 and interferon-alpha in metastatic renal cell carcinoma:results of a French regional experience in Languedoc[J].{H}American Journal of Clinical Oncology(CCT),2006,(02):148-152.
